PURPOSE: Few studies examine the relevance of health-related quality of life (HRQOL) instruments for young adult survivors of childhood cancer (YASCC). This study compared the psychometric properties of two survivor-specific instruments, the Quality of Life-Cancer Survivor (QOL-CS) and Quality of Life in Adult Cancer Survivor (QLACS). METHODS: Data from 151 YASCC who enrolled in cancer/tumor registries of two medical centers were used. We examined construct validity by conducting confirmatory factor analysis using indices of chi-square statistic, comparative fit index, and root mean square error of approximation. We examined convergent/discriminant validity by comparing Pearson's correlation coefficients of homogeneous (e.g., physical functioning and pain) of both instruments versus heterogeneous domains (e.g., physical and psychological functioning). We assessed known-groups validity by examining the extent to which HRQOL differed by late effects and comorbid conditions and calculated relative validity (RV) defined as contrasting F-statistics of individual domains to the domain with the lowest F-statistic. Superior known-groups validity is observed if a domain of one instrument demonstrates a higher RV than other domains of the instruments. RESULTS: YASCC data cannot replicate the constructs both instruments intend to measure, suggesting poor construct validity. Correlations of between-homogeneous and between-heterogeneous domains of both instruments were not discernible, suggesting poor convergent/discriminant validity. Both instruments were equally able to differentiate HRQOL between YASCC with and without late effects and comorbid conditions, suggesting similar known-groups validity. CONCLUSIONS: Neither instrument is superior. Item response theory is suggested to select high-quality items from different instruments to improve HRQOL measure for YASCC.
PURPOSE: Few studies examine the relevance of health-related quality of life (HRQOL) instruments for young adult survivors of childhood cancer (YASCC). This study compared the psychometric properties of two survivor-specific instruments, the Quality of Life-Cancer Survivor (QOL-CS) and Quality of Life in Adult Cancer Survivor (QLACS). METHODS: Data from 151 YASCC who enrolled in cancer/tumor registries of two medical centers were used. We examined construct validity by conducting confirmatory factor analysis using indices of chi-square statistic, comparative fit index, and root mean square error of approximation. We examined convergent/discriminant validity by comparing Pearson's correlation coefficients of homogeneous (e.g., physical functioning and pain) of both instruments versus heterogeneous domains (e.g., physical and psychological functioning). We assessed known-groups validity by examining the extent to which HRQOL differed by late effects and comorbid conditions and calculated relative validity (RV) defined as contrasting F-statistics of individual domains to the domain with the lowest F-statistic. Superior known-groups validity is observed if a domain of one instrument demonstrates a higher RV than other domains of the instruments. RESULTS:YASCC data cannot replicate the constructs both instruments intend to measure, suggesting poor construct validity. Correlations of between-homogeneous and between-heterogeneous domains of both instruments were not discernible, suggesting poor convergent/discriminant validity. Both instruments were equally able to differentiate HRQOL between YASCC with and without late effects and comorbid conditions, suggesting similar known-groups validity. CONCLUSIONS: Neither instrument is superior. Item response theory is suggested to select high-quality items from different instruments to improve HRQOL measure for YASCC.
Authors: Anne E Kazak; Branlyn Werba Derosa; Lisa A Schwartz; Wendy Hobbie; Claire Carlson; Richard F Ittenbach; Jun J Mao; Jill P Ginsberg Journal: J Clin Oncol Date: 2010-03-15 Impact factor: 44.544
Authors: Brad J Zebrack; Janet E Donohue; James G Gurney; Mark A Chesler; Smita Bhatia; Wendy Landier Journal: Qual Life Res Date: 2010-03 Impact factor: 4.147
Authors: Alysia Bosworth; Elizabeth L Goodman; Eric Wu; Liton Francisco; Leslie L Robison; Smita Bhatia Journal: Qual Life Res Date: 2017-08-02 Impact factor: 4.147
Authors: Gwendolyn P Quinn; I-Chan Huang; Devin Murphy; Katie Zidonik-Eddelton; Kevin R Krull Journal: Qual Life Res Date: 2013-02 Impact factor: 4.147
Authors: Nicholas S Phillips; Raja B Khan; Chenghong Li; Sedigheh Mirzaei Salehabadi; Tara M Brinkman; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull; Zsila S Sadighi Journal: Cancer Date: 2021-09-01 Impact factor: 6.860
Authors: I-Chan Huang; Tara M Brinkman; Gregory T Armstrong; Wendy Leisenring; Leslie L Robison; Kevin R Krull Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442